Breadcrumb Home Resources and Information Physicians and Scientists Resource Hub Asciminib Demonstrates Superior Efficacy and Safety In Newly Diagnosed Chronic Myeloid Leukemia In The ASC4FIRST Trial Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial Blood , Dec 2025 Cortes JE et al. Blood, December 2025 Link to full abstract Share Tweet Share Share